Showing results (11-20 of 222) with videos related to

Sort By:
Pageof 23
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 5, 2016
Long-Term Follow-Up and Treatment of Postoperative Permanent Hypoparathyroidism in Patients with Medullary Thyroid Carcinoma: Differences in Complete and Partial DiseaseG Leidig-Bruckner, T Bruckner, F Raue, et al.
Deutsche Medizinische Wochenschrift (1946)|January 22, 1993
[The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma]F Raue, S Geiger, H Buhr, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomyK Frank-Raue, W Höppner, H Buhr, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1995
Microsurgical neck dissection for metastasizing medullary thyroid carcinomaH J Buhr, F Kallinowski, F Raue, et al.
Deutsche Medizinische Wochenschrift (1946)|March 3, 1989
[Clinical features and diagnosis of mild 3-beta-hydroxysteroid dehydrogenase deficiency in men]K Frank-Raue, F Raue, S Korth-Schütz, et al.
Henry Ford Hospital Medical Journal|January 1, 1992
PDN-21 (katacalcin) and chromogranin A: tumor markers for medullary thyroid carcinomaF Raue, E Blind, A Grauer
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 29, 1998
Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitoninA Grauer, F Raue, R Ziegler
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Clinical significance of antibodies against calcitoninA Grauer, R Ziegler, F Raue
Pageof 23